Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic …

Background The direct oral thrombin inhibitor dabigatran has a predictable anticoagulant
effect and may be an alternative therapy to warfarin for patients who have acute venous …

Background VTE is a serious, but decreasing complication following major orthopedic
surgery. This guideline focuses on optimal prophylaxis to reduce postoperative pulmonary …

… Sam Schulman … Sam Schulman Sam Schulman …

Background This guideline addressed VTE prevention in hospitalized medical patients,
outpatients with cancer, the chronically immobilized, long-distance travelers, and those with …

Background High-quality anticoagulation management is required to keep these narrow
therapeutic index medications as effective and safe as possible. This article focuses on the …

Background Dabigatran, which is administered in a fixed dose and does not require
laboratory monitoring, may be suitable for extended treatment of venous thromboembolism. …

Background— Dabigatran and warfarin have been compared for the treatment of acute
venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those …

Background The optimal duration of oral anticoagulant therapy after a first episode of venous
thromboembolism is still a matter of debate. Methods We performed a multicenter trial …

Background The risk of stroke varies considerably across different groups of patients with
atrial fibrillation (AF). Antithrombotic prophylaxis for stroke is associated with an increased risk …